CFO appointment
MBX Biosciences, Inc. appoints John Smither as CFO
MBX Biosciences, Inc. reported in a Form 8-K filed July 13, 2026 that John Smither was appointed Chief Financial Officer and principal financial officer, effective July 13, 2026.
In the filing's words
On July 9, 2026, the Board appointed John Smither, the Company’s current interim Chief Financial Officer, as Chief Financial Officer and principal financial officer of the Company, effective as of July 13, 2026.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | MBX Biosciences, Inc. (MBX) |
|---|---|
| Event | Appointment |
| Incoming | John Smither |
| Title in the filing | Chief Financial Officer and principal financial officer |
| Effective | July 13, 2026 |
| 8-K filed | July 13, 2026 |
| Internal promotion | Yes |
| Prior role (per filing) | interim Chief Financial Officer, MBX Biosciences, Inc. |
| SEC CIK | 0001776111 |
MBX Biosciences, Inc. reported this change in a Form 8-K, Item 5.02, filed July 13, 2026. The filing's own words are quoted above.
Same industry, July 2026
7Other moves filed that month at companies the roster files under SIC “Pharmaceutical Preparations”.
3 months ago· 2026-07-31AppointmentGCAN
The Greater Cannabis Company, Inc. appoints Michelle Cervantes Vivanco as CFO
3 months ago· 2026-07-28TransitionVYNE
Yarrow Bioscience, Inc. CFO transition: Tyler Zeronda to succeed Mutya Harsch
3 months ago· 2026-07-22InterimKROS
Keros Therapeutics, Inc. names Annita Tanini interim CFO
3 months ago· 2026-07-20AppointmentPMHS
Polomar Health Services, Inc. appoints Douglas Beck as CFO
4 months ago· 2026-07-08TransitionOVID
Ovid Therapeutics Inc. CFO transition: Charles Carter to succeed Jeffrey Rona
4 months ago· 2026-07-06TransitionLGVN
Longeveron Inc. CFO transition: Marie Washburn to succeed Lisa Locklear
4 months ago· 2026-07-06AppointmentOGEN
Oragenics, Inc. appoints John Spencer as CFO
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about John Smither? Send a correction with the primary source.